NCT04896112 2023-06-18A Study of LNK01002 in Patients With Primary or Secondary Myelofibrosis,Polycythemia Vera or Acute Myeloid LeukemiaLynk Pharmaceuticals Co., LtdPhase 1 Withdrawn
NCT04283526 2021-03-04Study of Select Combinations in Adults With MyelofibrosisNovartisPhase 1 Withdrawn
NCT02871323 2019-08-20Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia MyelofibrosisNorthwestern UniversityPhase 1 Withdrawn